In silico identification and experimental validation of cellular uptake by a new cell penetrating peptide P1 derived from MARCKS.

Viral vectors for vaccine delivery are challenged by recently reported safety issues like immunogenicity and risk for cancer development, and thus there is a growing need for the development of non...